E speranza I . C abral, MD S ecretary of H ealth Keynote Address at

1. “. . . now is the time to stop butting heads and start linking arms. It is not impossible to work out a united plan that will be acceptable for all, and in the end will benefit those who need it most.” Esperanza I. Cabral, MD Secretary of Health Keynote Address at The 3rd MeTA Philippines Forum

2. SELF-REGULATION FOR ETHICALMEDICINE PROMOTIONIts Implementation and Impact Reiner W. Gloor Medicines Transparency Alliance 3rd National Forum January 26 to 27, 2010 Diamond Hotel

3. WHAT IS PHAP? A group of pharmaceutical companies engaged in extensive R&D to discover breakthrough treatments and provide access to quality medicines that save peoples’ lives. MEMBERSHIP Made up of 52 member companies, both local & multinational. Founded in 1946, these include companies engaged in research-based companies, generic companies, pharmaceutical distribution and marketing companies, medical devices manufacturers, health research companies, over-the-counter pharmaceutical manufacturing companies and pharmaceutical retailers.

4. GOALS & PRINCIPLES GOVERNING PRINCIPLES • Good governance • Management needs review • Manage stakeholders’ relations such as Promo Program PHAP GOALS • Foster good governance • Review and update Ethics Code to adhere to international standards (IFMA-EPM, US Pharma)

5. PHAP ETHICS COMMITTEE ENFORCEMENT • Formulate, promote and demonstrate adopted Code • Make Code a living instrument to support ethical, promotional and monitoring activities • Adjudicate cases and enforce Code

6. PHAP Ethics Committee • DR. ALBERTO ROMUALDEZ • Chairman, MeTA • Formerly Secretary of Health • MR. REINER W. GLOOR • Executive Director, PHAP • PROF. JACINTO GAVINO • Asian Institute of Management • Holder of Fr. James Donelan, S.J. • Chair in Business Ethics • DR. ANTONETTE PALMA-ANGELES • Ateneo De Manila University • Vice President for Academics • Ethics Professor • DR. BENITO TEEHANKEE • Holder of Sen. Benigno, Jr. Chair in • Business and Governance • Ethics Associate Professor • Ramon V. del Rosario Sr. Graduate • School of Business,De La Salle University • FR. NEMESIO QUE, S.J. • Ateneo De Manila University • Director Admission • DR. GUIA TANAteneo School of Medicine and Public Health, • Ethics Subject Expert and Head & Neck FacultyMember, Bioethics Committee-UP-PGH Medical Ctr

7. STRATEGIES ADVOCACY & TRAINING PHAP Awareness Campaign with Medical Associations/Societies Phil. Medical Association Philippine College of Physicians Philippine Society of Opthalmology Hospital Pharmacists Association of the Philippines Philippine Neurological Association Medical Doctors, Marketing & Sales people or member Pharma Companies, NGOs, Academe (De La Salle University)

8. STRATEGIES Internal Training Workshops Conducted/Organized Code-related training sessions: 12 sessions in 2005 with 556 participants 8 in 2006 with 572 participants 6 sessions in 2007 with 302 participants 6 in 2008 with 362 participants Dialogues • Companies • Regulators • Stakeholders

9. PUBLIC INFORMATION External Outreach Activities • Media Roundtable in 2009 • Tri-Media Exposure through Press Releases and Interviews

10. RESULTS/IMPACT • Reform in companies • Appointment of Compliance Officer • Internal Training of Medical Representatives/Marketing Staff

11. TOP FIVE VIOLATIONS

12. TOP FIVE VIOLATIONS

14. RESULTS/IMPACT

15. RESULTS/IMPACT

16. Thank You & Good Day

17. “. . . now is the time to stop butting heads and start linking arms. It is not impossible to work out a united plan that will be acceptable for all, and in the end will benefit those who need it most.” Esperanza I. Cabral, MD Secretary of Health Keynote Address at The 3rd MeTA Philippines Forum